 MINNEAPOLIS, July 29, 2021 GLOBE NEWSWIRE -- CVRx, Inc. CVRx, a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will participate in the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021. The Company is scheduled to present at the conference at 11:00 am Eastern Time the same day via webcast. 